ArticleCurrent oncology (Toronto, Ont.)2025

A Recurrent Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion Mutation with Sustained Response to Ensartinib: A Case Report.

Hao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.